Fund shareholders of Vertex Pharmaceuticals Inc
ISIN US92532F1003 · United States · LEI 54930015RAQRRZ5ZGJ91
- Fund shareholders
- 1,198
- Of which ETFs
- 310 888 other funds
- Value held
- 56.9B $ 143.7M € · 5.3B SEK
1,198 funds hold this company. This table lists the 1,185 that declare it in a regulatory filing. The other 13 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 50,958 | 21.8M $ | 1.93 % | as of Apr 30, 2026 ↗ |
| Länsförsäkringar Global Index Länsförsäkringar Fondförvaltning AB | 50,645 | 215.4M SEK | 0.17 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs U.S. Tax-Managed Equity Fund Goldman Sachs Trust | 50,265 | 22.4M $ | 0.54 % | as of Mar 31, 2026 ↗ |
| DAVENPORT CORE LEADERS FUND Williamsburg Investment Trust | 49,884 | 22.3M $ | 1.92 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 1500(R) Composite Stock Market ETF SPDR SERIES TRUST | 49,774 | 22.2M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| iShares Future Exponential Technologies ETF iShares Trust | 49,397 | 21.1M $ | 0.55 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Large Cap Growth Insights Fund Goldman Sachs Trust | 48,895 | 20.9M $ | 1.26 % | as of Apr 30, 2026 ↗ |
| LVIP AllianceBernstein Large Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 48,761 | 21.8M $ | 1.47 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Large Company ETF SCHWAB STRATEGIC TRUST | 48,394 | 24M $ | 0.10 % | as of Feb 28, 2026 ↗ |
| Columbia Variable Portfolio - Contrarian Core Fund COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 48,076 | 21.5M $ | 1.38 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 47,214 | 23.5M $ | 0.10 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 45,914 | 22.8M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| JPMorgan U.S. Large Cap Core Plus Fund JPMorgan Trust I | 45,816 | 20.5M $ | 0.63 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Nasdaq-100 Premium Income ETF Goldman Sachs ETF Trust | 45,373 | 20.3M $ | 0.65 % | as of Mar 31, 2026 ↗ |
| First Trust WCM Focused Global Growth Fund First Trust Series Fund | 44,910 | 20.1M $ | 1.67 % | as of Mar 31, 2026 ↗ |
| Jennison Growth Portfolio Brighthouse Funds Trust II | 44,531 | 19.9M $ | 0.79 % | as of Mar 31, 2026 ↗ |
| Calamos Market Neutral Income Fund CALAMOS INVESTMENT TRUST/IL | 43,937 | 18.8M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Invesco MSCI USA ETF Invesco Exchange-Traded Fund Trust II | 43,734 | 21.7M $ | 0.21 % | as of Feb 28, 2026 ↗ |
| SA Wellington Capital Appreciation Portfolio SUNAMERICA SERIES TRUST | 43,383 | 19.4M $ | 0.90 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 43,075 | 21.4M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| PSF Stock Index Portfolio Prudential Series Fund | 42,900 | 19.2M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| LVIP Blended Large Cap Growth Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 42,537 | 19M $ | 1.28 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 42,392 | 180.3M SEK | 0.19 % | as of Mar 31, 2026 ↗ |
| Columbia Disciplined Core Fund Columbia Funds Series Trust II | 42,117 | 18M $ | 0.36 % | as of Apr 30, 2026 ↗ |
| EQUITY INDEX FUND GuideStone Funds | 41,679 | 18.6M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| JPMorgan Hedged Equity 2 Fund JPMorgan Trust IV | 41,278 | 18.4M $ | 0.34 % | as of Mar 31, 2026 ↗ |
| Empower S&P 500 Index Fund EMPOWER FUNDS, INC. | 41,160 | 18.4M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 40,946 | 17.5M $ | 2.40 % | as of Apr 30, 2026 ↗ |
| AMF Aktiefond Världen AMF Fonder AB | 40,442 | 172M SEK | 0.32 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 39,149 | 17.5M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Research Fund JANUS INVESTMENT FUND | 38,730 | 17.3M $ | 0.42 % | as of Mar 31, 2026 ↗ |
| iShares ESG MSCI KLD 400 ETF iShares Trust | 38,712 | 16.5M $ | 0.32 % | as of Apr 30, 2026 ↗ |
| MetLife Stock Index Portfolio Brighthouse Funds Trust II | 38,710 | 17.3M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| LargeCap Growth Fund I Principal Funds, Inc | 38,668 | 16.5M $ | 0.27 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 38,593 | 19.2M $ | 0.09 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Large-Cap Growth Index Fund SCHWAB CAPITAL TRUST | 38,479 | 16.4M $ | 0.35 % | as of Apr 30, 2026 ↗ |
| JNL/Loomis Sayles Global Growth Fund JNL Series Trust | 37,756 | 16.9M $ | 2.16 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Global Min Vol Factor ETF iShares, Inc. | 37,495 | 18.6M $ | 0.52 % | as of Feb 28, 2026 ↗ |
| Fidelity U.S. Sustainability Index Fund Fidelity Salem Street Trust | 37,037 | 15.8M $ | 0.29 % | as of Apr 30, 2026 ↗ |
| NEOS S&P 500(R) High Income ETF NEOS ETF Trust | 36,609 | 16.3M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 36,045 | 16.1M $ | 2.43 % | as of Mar 31, 2026 ↗ |
| Large Cap Equity Fund American Century Mutual Funds, Inc. | 35,704 | 15.3M $ | 0.49 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex 500 Index Fund Fidelity Concord Street Trust | 34,713 | 17.2M $ | 0.21 % | as of Feb 28, 2026 ↗ |
| VOYA LARGE CAP VALUE FUND Voya Equity Trust | 34,312 | 17M $ | 1.05 % | as of Feb 28, 2026 ↗ |
| Columbia Cornerstone Equity Fund COLUMBIA FUNDS SERIES TRUST | 34,172 | 17M $ | 1.08 % | as of Feb 28, 2026 ↗ |
| AB Growth Fund AB PORTFOLIOS | 33,929 | 14.5M $ | 0.94 % | as of Apr 30, 2026 ↗ |
| Large-Cap Core Portfolio PACIFIC SELECT FUND | 33,895 | 15.1M $ | 0.76 % | as of Mar 31, 2026 ↗ |
| Capital World Growth & Income Fund AMERICAN FUNDS INSURANCE SERIES | 33,467 | 14.9M $ | 0.75 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Focused Growth Fund Prudential Investment Portfolios 3 | 33,191 | 16.5M $ | 1.03 % | as of Feb 27, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 32,642 | 14M $ | 0.12 % | as of Apr 30, 2026 ↗ |
| Columbia Variable Portfolio - Disciplined Core Fund Columbia Funds Variable Series Trust II | 32,571 | 14.5M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| EQ/JPMorgan Value Opportunities Portfolio EQ Advisors Trust | 32,136 | 14.4M $ | 1.18 % | as of Mar 31, 2026 ↗ |
| NVIT J.P. Morgan U.S. Equity Fund Nationwide Variable Insurance Trust | 32,125 | 14.3M $ | 0.76 % | as of Mar 31, 2026 ↗ |
| Index 500 Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 32,099 | 14.3M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| JPMORGAN BETABUILDERS U.S. EQUITY ETF J.P. Morgan Exchange-Traded Fund Trust | 32,014 | 13.7M $ | 0.17 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 31,324 | 15.6M $ | 0.11 % | as of Feb 28, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 31,300 | 14M $ | 0.19 % | as of Mar 31, 2026 ↗ |
| AB Large Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 30,945 | 13.8M $ | 1.51 % | as of Mar 31, 2026 ↗ |
| EQ/500 Managed Volatility Portfolio EQ Advisors Trust | 30,785 | 13.7M $ | 0.18 % | as of Mar 31, 2026 ↗ |
| U.S. Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 30,326 | 13M $ | 0.16 % | as of Apr 30, 2026 ↗ |
| Handelsbanken USA Index Criteria Handelsbanken Fonder AB | 30,251 | 128.7M SEK | 0.29 % | as of Mar 31, 2026 ↗ |
| Columbia Large Cap Growth Opportunity Fund COLUMBIA FUNDS SERIES TRUST | 30,175 | 15M $ | 1.24 % | as of Feb 28, 2026 ↗ |
| JPMorgan Hedged Equity Laddered Overlay ETF J.P. Morgan Exchange-Traded Fund Trust | 30,006 | 12.8M $ | 0.32 % | as of Apr 30, 2026 ↗ |
| Columbia Variable Portfolio - Balanced Fund Columbia Funds Variable Series Trust II | 29,695 | 13.3M $ | 0.83 % | as of Mar 31, 2026 ↗ |
| Calvert U.S. Large Cap Core Responsible Index Fund Calvert Responsible Index Series, Inc. | 29,638 | 13.2M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Dimensional US Large Cap Value ETF Dimensional ETF Trust | 29,340 | 12.5M $ | 0.21 % | as of Apr 30, 2026 ↗ |
| Invesco Equally-Weighted S&P 500 Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 29,016 | 14.4M $ | 0.20 % | as of Feb 28, 2026 ↗ |
| Stock Index Fund VALIC Co I | 28,439 | 14.1M $ | 0.21 % | as of Feb 28, 2026 ↗ |
| Equity Index Portfolio PACIFIC SELECT FUND | 28,319 | 12.6M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| State Street U.S. Core Equity Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 27,680 | 12.4M $ | 0.33 % | as of Mar 31, 2026 ↗ |
| Nasdaq-100 Index Fund SHELTON FUNDS | 27,135 | 13.5M $ | 0.67 % | as of Feb 28, 2026 ↗ |
| MOA EQUITY INDEX FUND MoA Funds Corp | 26,218 | 11.7M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| iShares ESG Optimized MSCI USA ETF iShares Trust | 25,588 | 10.9M $ | 0.29 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs U.S. Equity Insights Fund Goldman Sachs Trust | 25,555 | 10.9M $ | 0.97 % | as of Apr 30, 2026 ↗ |
| Harding Loevner Global Equity Portfolio HARDING LOEVNER FUNDS INC | 25,545 | 10.9M $ | 2.03 % | as of Apr 30, 2026 ↗ |
| Avanza Global Avanza Fonder AB | 25,496 | 108.5M SEK | 0.25 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Janus Henderson Balanced Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 25,404 | 11.3M $ | 0.59 % | as of Mar 31, 2026 ↗ |
| NASDAQ-100 Fund Rydex Series Funds | 25,329 | 11.3M $ | 0.61 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 25,240 | 11.3M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| NYLIM VP S&P 500 Index Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 25,167 | 11.2M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 25,010 | 105.7M SEK | 3.32 % | as of Mar 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 25,000 | 11.2M $ | 1.68 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Tech Breakthrough Multisector ETF iShares Trust | 24,987 | 10.7M $ | 2.36 % | as of Apr 30, 2026 ↗ |
| Invesco S&P 500 Equal Weight Health Care ETF Invesco Exchange-Traded Fund Trust | 24,889 | 10.6M $ | 1.54 % | as of Apr 30, 2026 ↗ |
| Victory Pioneer Core Equity Fund Victory Portfolios IV | 24,851 | 11.1M $ | 0.57 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1000 ETF Invesco Exchange-Traded Fund Trust | 24,837 | 10.6M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| NVIT S&P 500 Index Fund Nationwide Variable Insurance Trust | 24,782 | 11.1M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Large Company Index Fund SCHWAB CAPITAL TRUST | 24,676 | 10.5M $ | 0.09 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) MSCI USA StrategicFactors(SM) ETF SPDR SERIES TRUST | 24,584 | 11M $ | 0.75 % | as of Mar 31, 2026 ↗ |
| Trillium ESG Global Equity Fund Perpetual Americas Funds Trust | 24,206 | 10.8M $ | 1.55 % | as of Mar 31, 2026 ↗ |
| Direxion NASDAQ-100 Equal Weighted Index Shares Direxion Shares ETF Trust | 24,112 | 10.3M $ | 0.85 % | as of Apr 30, 2026 ↗ |
| Schwab Health Care Fund SCHWAB CAPITAL TRUST | 24,059 | 10.3M $ | 1.67 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Large Cap Growth Fund Federated Hermes MDT Series | 23,862 | 10.2M $ | 0.20 % | as of Apr 30, 2026 ↗ |
| Motley Fool 100 Index ETF RBB Fund, Inc. | 23,666 | 11.8M $ | 0.62 % | as of Feb 28, 2026 ↗ |
| Venerable US Large Cap Strategic Equity Fund Venerable Variable Insurance Trust | 23,555 | 10.5M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Global Equity Fund RUSSELL INVESTMENT CO | 23,128 | 9.9M $ | 0.26 % | as of Apr 30, 2026 ↗ |
| ClearBridge Variable Large Cap Growth Portfolio Legg Mason Partners Variable Equity Trust | 22,996 | 10.3M $ | 1.97 % | as of Mar 31, 2026 ↗ |
| EQ/Large Cap Growth Index Portfolio EQ Advisors Trust | 22,686 | 10.1M $ | 0.41 % | as of Mar 31, 2026 ↗ |
| Calamos Growth & Income Fund CALAMOS INVESTMENT TRUST/IL | 22,615 | 9.7M $ | 0.29 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Developed Markets Index Criteria Handelsbanken Fonder AB | 22,374 | 95.2M SEK | 0.21 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9.30 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Biotech Top 5 Bull 2X ETF Direxion Shares ETF Trust | 8.22 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 8.06 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 7.44 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6.27 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 5.60 % | as of Mar 31, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 5.44 % | as of Feb 27, 2026 ↗ |
| ClearBridge Variable Growth Portfolio Legg Mason Partners Variable Equity Trust | 5.33 % | as of Mar 31, 2026 ↗ |
| Virtus KAR Health Sciences Fund Virtus Investment Trust | 5.09 % | as of Mar 31, 2026 ↗ |
| Natixis Loomis Sayles Focused Growth ETF Natixis ETF Trust II | 4.55 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1,048 | +76 | 123,815,099 | +2.9 % |
| 2026Q1 | 972 | -29 | 120,276,157 | +1.8 % |
| 2025Q4 | 1,001 | -22 | 118,183,576 | -3.6 % |
| 2025Q3 | 1,023 | -31 | 122,642,833 | +1.6 % |
| 2025Q2 | 1,054 | +33 | 120,769,763 | +3.2 % |
| 2025Q1 | 1,021 | -78 | 117,052,590 | +2.0 % |
| 2024Q4 | 1,099 | -59 | 114,791,743 | +0.8 % |
| 2024Q3 | 1,158 | -31 | 113,844,744 | +1.6 % |
| 2024Q2 | 1,189 | -2 | 112,003,751 | +5.6 % |
| 2024Q1 | 1,191 | -6 | 106,033,489 | -4.0 % |
| 2023Q4 | 1,197 | 110,442,131 |
Institutional managers
1,670 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Capital World Investors | 25,368,124 | 11.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 23,969,517 | 10.7B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 21,125,964 | 9.4B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 11,730,139 | 5.2B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 7,033,156 | 3.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,139,621 | 2.7B $ | as of Mar 31, 2026 |
| Capital International Investors | 5,126,077 | 2.3B $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 4,003,821 | 1.8B $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 3,910,786 | 1.8B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,212,589 | 1.4B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,188,881 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,057,396 | 1.4B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,878,183 | 1.3B $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 2,740,059 | 1.2B $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 2,700,975 | 1.2B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 2,633,481 | 1.2B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,564,264 | 1.1B $ | as of Mar 31, 2026 |
| Invesco Ltd. | 2,561,057 | 1.1B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,417,875 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,131,527 | 951.8M $ | as of Mar 31, 2026 |
| FMR LLC | 2,020,265 | 902.1M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,955,764 | 873.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,920,871 | 857.7M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 1,888,521 | 843.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,760,122 | 786K $ | as of Mar 31, 2026 |
Declared shareholders of Vertex Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Capital World Investors | 10.10 % | 25,695,015 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 8.30 % | 21,139,169 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 7.49 % | 19,036,076 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Vertex Pharmaceuticals Inc". https://titelia.com/en/stocks/vertex-pharmaceuticals-inc-US92532F1003